MeSH term
Frequency | Condition_Probility | Amino Acid Sequence | 8 | 0.0 |
Animals | 13 | 0.0 |
Basement Membrane/metabolism | 4 | 6.0 |
Laminin/analysis | 2 | 6.0 |
Mice | 9 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Mice, Knockout | 6 | 0.0 |
Molecular Sequence Data | 15 | 0.0 |
Research Support, Non-U.S. Gov't | 33 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 18 | 0.0 |
Adolescent | 8 | 0.0 |
Adult | 15 | 0.0 |
Aged | 4 | 0.0 |
Child | 10 | 0.0 |
DNA Mutational Analysis | 6 | 0.0 |
Exons | 5 | 0.0 |
Female | 23 | 0.0 |
Genes, Dominant | 5 | 0.0 |
Hematuria/*genetics | 2 | 40.0 |
Humans | 41 | 0.0 |
*Linkage (Genetics) | 4 | 0.0 |
Male | 23 | 0.0 |
Middle Aged | 6 | 0.0 |
Pedigree | 15 | 0.0 |
Polymorphism, Genetic | 2 | 0.0 |
*Disease Models, Animal | 3 | 0.0 |
Disease Progression | 2 | 0.0 |
Nephritis, Hereditary/*genetics/physiopathology | 2 | 100.0 |
Base Sequence | 15 | 0.0 |
Chromosomes, Human, Pair 2/genetics | 3 | 2.0 |
Collagen Type IV/*genetics | 8 | 40.0 |
DNA/genetics | 2 | 0.0 |
Homozygote | 2 | 0.0 |
Linkage (Genetics) | 7 | 0.0 |
*Mutation | 10 | 0.0 |
Nephritis, Hereditary/*genetics/pathology | 2 | 28.0 |
Phenotype | 6 | 0.0 |
Collagen/*genetics | 14 | 3.0 |
DNA, Complementary/genetics | 2 | 0.0 |
Heterozygote | 4 | 0.0 |
Introns | 4 | 0.0 |
Mutation, Missense | 2 | 0.0 |
Nephritis, Hereditary/*genetics | 8 | 21.0 |
Polymorphism, Single-Stranded Conformational | 3 | 0.0 |
*Genes, Dominant | 2 | 0.0 |
Mutation/genetics | 3 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Basement Membrane/metabolism/pathology | 2 | 16.0 |
Chromosome Mapping | 4 | 0.0 |
Collagen/*genetics/metabolism | 3 | 8.0 |
Disease Models, Animal | 4 | 0.0 |
Kidney/pathology | 5 | 3.0 |
Mice, Transgenic | 2 | 0.0 |
Nephritis, Hereditary/*genetics/metabolism/pathology | 2 | 50.0 |
Promoter Regions (Genetics) | 4 | 0.0 |
Sequence Deletion | 2 | 0.0 |
Basement Membrane/pathology | 4 | 11.0 |
Gene Deletion | 2 | 0.0 |
Gene Expression Regulation | 2 | 0.0 |
Kidney Glomerulus/pathology | 4 | 8.0 |
Leiomyomatosis/genetics | 2 | 40.0 |
Antibodies, Monoclonal | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Consanguinity | 3 | 0.0 |
*Genes, Recessive | 2 | 1.0 |
Biopsy | 4 | 0.0 |
Nephritis, Hereditary/*genetics/*pathology | 2 | 50.0 |
Polymerase Chain Reaction | 6 | 0.0 |
Extracellular Matrix Proteins/metabolism | 2 | 2.0 |
Fibrosis | 2 | 1.0 |
Transplantation, Homologous | 2 | 0.0 |
Amino Acid Substitution | 3 | 0.0 |
Comparative Study | 3 | 0.0 |
Exons/genetics | 2 | 0.0 |
Frameshift Mutation | 2 | 0.0 |
*Point Mutation | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
DNA Primers | 2 | 0.0 |
Genes, Recessive | 4 | 0.0 |
Glycine | 2 | 2.0 |
Heterozygote Detection | 2 | 0.0 |
Microscopy, Electron | 3 | 0.0 |
Mutation | 4 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Autoantigens/*genetics | 3 | 4.0 |
Molecular Structure | 2 | 0.0 |
Point Mutation | 2 | 0.0 |
Child, Preschool | 2 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Fluorescent Antibody Technique | 3 | 0.0 |
Mutation/*genetics | 3 | 0.0 |
Basement Membrane/immunology | 2 | 3.0 |
Kidney Glomerulus/immunology | 2 | 6.0 |
Genes, Recessive/*genetics | 2 | 3.0 |
*Chromosomes, Human, Pair 2 | 2 | 0.0 |
Blotting, Northern | 2 | 0.0 |
Mutation, Missense/genetics | 2 | 1.0 |
Basement Membrane/*pathology | 2 | 40.0 |
Risk Factors | 2 | 0.0 |
X Chromosome | 2 | 0.0 |
